Honokiol: a comprehensive scientific review of benefits, mechanisms and applications
Summary
Honokiol is a bioactive compound extracted from the bark, leaves and seed cones of the Magnolia genus. This natural polyphenol -based substance has been used for centuries in traditional Chinese and Japanese medicine to promote health and well -being. Modern research has documented a wide range of therapeutic benefits, including antioxidant, anti -inflammatory, neurobic and cardi -protecting properties. In addition, preclinical and clinical studies show that honokiol has significant antitumor properties, where it can modulate important signal paths involved in cancer development. In this extensive review, Honokiol's chemical structure, biological mechanisms of action, therapeutic potential, clinical implications and safety profile are explored.
Honokiol's chemical structure and properties
Honociol (C18H18O2) is a small, lipophilic molecular structure that allows it to easily cross the blood-brain barrier and have systemic effects. It belongs to the Neolnan Bifenols class and shares structural similarities to propofol, an anesthetic known for its potent Gaba_a receptor modulating effect. Honokiol's hydrophobic properties contribute to its biological availability and make it easily absorbed in lipid membranes, which reinforces its pharmacological activity.
DHH-B (DiHydrohonokiol-B) vs. Honey
DHH-B is a modified form of honey extracted from Magnoliabark. Both compounds have strong bioactive properties, but they have some important differences:
-
Concentration and effect:
- DHH-B is a more potent form of honokiol and has a stronger effect on anxiety reduction.
- Honociol has a wider range of pharmacological effects, including antioxidant, anti-inflammatory and anti-cancer properties.
-
Mechanism of action:
- DHH-B works primarily by reinforcing the activity of GABA_A receptors, which gives a more powerful soothing effect without side effects such as drowsiness or addiction.
- Honokiol has a similar effect on GABA_A receptors, but also has the ability to modulate signaling pathways related to inflammation, oxidative stress and apoptosis.
-
Side effects:
- DHH-B has fewer side effects than traditional anxiety-reducing drugs such as benzodiazepines and are less likely to lead to addiction.
- Honociol is also well tolerated, but at higher doses it can cause mild sedation.
-
Applications:
- DHH-B is used primarily to relieve anxiety and stress.
- Honociol is used in a broader context, including cancer prevention, inflammatory reduction, neurobic protection and heart disease.
Pharmacokinetics and metabolism
Honociol is quickly absorbed through the gastrointestinal tract and effectively distributed to various tissues, including the brain, due to its lipophile nature. Studies show that honey is metabolized in the liver via cytochrome P450 enzymes (CYP450) and conjugated with glucuronic acid before excretion via urine and bile. The half -life varies depending on the dosage, but is often reported to be between 2-6 hours in preclinical studies.
Pharmacological and therapeutic properties
-
Antioxidant activity:
- Honociol acts as a strong antioxidant by reducing oxidative stress and protecting cells from lipid peroxidation.
- It inhibits the production of reactive oxygen compounds (ROS) and improves the body's natural antioxidant defense.
-
Anti-inflammatory properties:
- Blocking the NF-κB signaling pathway, a central regulator of inflammation response.
- Reduces the production of pro-inflammatory cytokines, including TNF-α, IL-6 and IL-1β.
-
Neurobic Spring effects:
- Honociol crosses the blood-brain barrier and has shown neurobic protection by inhibiting neuroin flammation and oxidative stress.
- Studies have shown promising results in the treatment of Alzheimer's disease, Parkinson's disease and stroke.
-
Antimicrobial and antiviral properties:
- Honociol has antibacterial effect against several pathogenic bacteria, including methicillin -resistant Staphylococcus aureus (MRSA).
- It inhibits viral replication and has shown activity against hepatitis C virus.
-
Cancer -inhibiting properties:
- Honociol has shown the ability to inhibit cell proliferation and induce apoptosis in a variety of cancer types, including breast, prostate, lung, colon and brain cancer.
- It inhibits angiogenesis, tumor growth and metastasis through several signaling pathways, including P53, BCL-2, Stat3, MTOR and Amp.
-
Heart -healthy effects:
- Honociol can help reduce blood pressure and improve endothelial function.
- It protects against atherosclerosis by inhibiting the oxidation of LDL cholesterol.
-
Metabolic regulation:
- Honokiol has shown the ability to improve insulin response and reduce blood sugar levels, which can have beneficial effects in type 2 diabetes.
-
Psychological and neuropsychiatric benefits:
- Has anxiety-reducing and antidepressant effect through GABA_A receptor modulation.
- Can improve sleep quality without the addictive side effects of benzodiazepines.
Security and side effects
Honokiol and DHH-B are generally considered safe, but some side effects may occur at higher doses:
- Mild sedation and drowsiness
- Gastrointestinal ailments
- Potential interactions with blood thinners
- Reduced motor coordination at very high doses
Disclaim
Use of this product should be done in consultation with qualified health professionals. Keep out of reach of children. Uno Vita AS does not claim that the product can cure disease. The information is intended for educational purposes only and should not replace medical advice.
Freedom of speech and right to information
Uno Vita reserves the right to share publicly available research on health and wellness technologies in accordance with:
- UN Human Rights (1948), Article 19
- The International Convention on Civil and Political Rights (1966), Article 19
- Norwegian Constitution § 100
- US First Amendment
References
-
Chen, X., et al. (2021). "Antioxidant and anti-inflammatory Properties of Honokiol: A Systematic Review." Journal of Natural Products, 84(6), 1203-1217.
-
Wang, Y., et al. (2020). "Honokiol as a potential anticancer agent: molecular mechanisms and therapeutic applications." Cancer Letters, 485, 50-60.
-
Lee, J., et al. (2019). "Effects of Honokiol on Metabolic Disorders and Insulin Resistance: A Review." Frontiers in pharmacology, 10, 345.
-
Zhang, P., et al. (2022). "Neuroprotective Effects of Honokiol: Insights from Molecular Mechanisms and Clinical Applications." Neuroscience Letters, 776, 136781.
-
Liu, H., et al. (2018). "Honokiol modulates inflammatory pathways in chronic diseases." Molecular Nutrition & Food Research, 62 (7), E1800062.
-
Kim, D., et al. (2021). "Pharmacokinetics and Biotransformation of Honokiol in Human Liver Microsomes." Drug metabolism reviews, 53(2), 112-124.
-
Ma, X., et al. (2020). "Honokiol's Role in Cardiovascular Protection: Mechanistic Insights and Potential Clinical Applications." Cardiovascular Research, 116(4), 693-705.
-
Sun, W., et al. (2019). "Honokiol's Effect on Anxiety and Sleep Disorders: A Preclinical Study." Journal of Neuroscience Research, 97(10), 1048-1056.
-
Tan, C., et al. (2022). "Lipid-Solubility and Bioavailability of Honokiol: Implications for Therapeutic Use." Pharmacological reports, 74(1), 223-233.
-
Zhao, Z., et al. (2018). "Honokiol's Impact on TNF-α Signaling and Inflammatory Response." Inflammation Research, 67(3), 191-203.
-
Park, J., et al. (2020). "Honokiol and Its Effect on CYP450 Enzymes: Implications for Drug Interactions." Expert Opinion on Drug Metabolism & Toxicology, 16(6), 487-499.
-
He, L., et al. (2021). "Potential Role of Honokiol in Modulating Oxidative Stress in Age-Related Disorders." Aging research reviews, 69, 101343.
-
Rauf, A., et al. (2021). "Honokiol: A Review of Its Pharmacological Potential and Therapeutic Insights." Phytomedicine, 92, 153647.
-
Woodbury, A., et al. (2013). "Neuro modulating Effects of Honokiol: A Review." Frontiers in neurology, 4, 130.
-
Fried, L. E., & Arbiser, J. L. (2009). "Honokiol, a multifunctional antiangiogenic and antitumor agent." Antioxidants & Redox Signaling, 11(5), 1139-1148.
-
Arora, S., et al. (2012). "Honokiol: A Novel Natural Agent for Cancer Prevention and Therapy." Current Molecular Medicine, 12(10), 1244-1252.
-
Ponnusamy, K., & Choi, J. N. (2012). "Honokiol: an Emerging Natural Agent for Cancer Therapy." Journal of Biomedicine and Biotechnology, 2012, 1-10.
-
Fried, L. E., & Arbiser, J. L. (2009). "Honokiol, a multifunctional antiangiogenic and antitumor agent." Antioxidants & Redox Signaling, 11(5), 1139-1148.
-
Arora, S., et al. (2012). "Honokiol: A Novel Natural Agent for Cancer Prevention and Therapy." Current Molecular Medicine, 12(10), 1244-1252.
-
Ponnusamy, K., & Choi, J. N. (2012). "Honokiol: an Emerging Natural Agent for Cancer Therapy." Journal of Biomedicine and Biotechnology, 2012, 1-10.